Yi-Ji Liao

1.6k total citations
20 papers, 1.3k citations indexed

About

Yi-Ji Liao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yi-Ji Liao has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Yi-Ji Liao's work include MicroRNA in disease regulation (6 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (4 papers). Yi-Ji Liao is often cited by papers focused on MicroRNA in disease regulation (6 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (4 papers). Yi-Ji Liao collaborates with scholars based in China and Hong Kong. Yi-Ji Liao's co-authors include Dan Xie, Yi-Xin Zeng, Jiaxing Zhang, Hsiang‐Fu Kung, Jinhuan Wei, Shi-Juan Mai, Ming Hu, Song Wu, Jian Lei and Wei Chen and has published in prestigious journals such as Scientific Reports, The Lancet Oncology and Virology.

In The Last Decade

Yi-Ji Liao

20 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi-Ji Liao China 15 859 506 237 175 126 20 1.3k
Quintin Pan United States 24 1.2k 1.4× 442 0.9× 631 2.7× 163 0.9× 84 0.7× 44 1.8k
Jason R. Pitarresi United States 15 959 1.1× 467 0.9× 830 3.5× 256 1.5× 151 1.2× 36 1.8k
Zhennan Yuan China 12 486 0.6× 324 0.6× 278 1.2× 171 1.0× 70 0.6× 30 1.1k
Yongfu Zhao China 24 923 1.1× 529 1.0× 261 1.1× 158 0.9× 178 1.4× 60 1.5k
Xinzheng Dai China 18 407 0.5× 196 0.4× 196 0.8× 144 0.8× 148 1.2× 29 877
Alexei V. Salnikov Germany 17 870 1.0× 433 0.9× 802 3.4× 153 0.9× 68 0.5× 23 1.6k
Zubaidah Zakaria Malaysia 22 577 0.7× 223 0.4× 317 1.3× 71 0.4× 200 1.6× 69 1.3k
Xin Song China 16 662 0.8× 385 0.8× 211 0.9× 120 0.7× 61 0.5× 31 921
Kazunori Otsuka Japan 11 717 0.8× 276 0.5× 659 2.8× 117 0.7× 72 0.6× 24 1.2k
Ling Cen United States 17 626 0.7× 197 0.4× 569 2.4× 151 0.9× 58 0.5× 44 1.3k

Countries citing papers authored by Yi-Ji Liao

Since Specialization
Citations

This map shows the geographic impact of Yi-Ji Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-Ji Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-Ji Liao more than expected).

Fields of papers citing papers by Yi-Ji Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi-Ji Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-Ji Liao. The network helps show where Yi-Ji Liao may publish in the future.

Co-authorship network of co-authors of Yi-Ji Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Yi-Ji Liao. A scholar is included among the top collaborators of Yi-Ji Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi-Ji Liao. Yi-Ji Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Fang, Mu-Yan Cai, Lin Guo, et al.. (2016). The putative tumor activator ARHGEF3 promotes nasopharyngeal carcinoma cell pathogenesis by inhibiting cellular apoptosis. Oncotarget. 7(18). 25836–25848. 16 indexed citations
2.
Jiang, Hua, Xiao Wang, Qian Xue, et al.. (2016). Anti-cancer effects of curcumin on lung cancer through the inhibition of EZH2 and NOTCH1. Oncotarget. 7(18). 26535–26550. 75 indexed citations
3.
Zhang, Yi, Jiaxing Zhang, Yi-Ji Liao, et al.. (2015). Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma. Tumor Biology. 36(6). 4405–4415. 6 indexed citations
4.
Wang, Xiao, et al.. (2015). Evidence for transcriptional interference in a dual-luciferase reporter system. Scientific Reports. 5(1). 17675–17675. 10 indexed citations
5.
He, Lei, et al.. (2014). OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma. Molecular Cancer. 13(1). 191–191. 75 indexed citations
6.
Zhang, Jiaxing, Song Wu, Zhenhua Chen, et al.. (2013). Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. The Lancet Oncology. 14(13). 1295–1306. 450 indexed citations
7.
Li, Frank Yonghong, Huan-Xin Lin, Yi-Ji Liao, et al.. (2013). Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder. BMC Cancer. 13(1). 349–349. 85 indexed citations
8.
Qian, Dong, Li-Ru He, Frank Yonghong Li, et al.. (2013). PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway. Molecular Cancer. 12(1). 148–148. 28 indexed citations
9.
Zhao, Lei, Li-Ru He, Mian Xi, et al.. (2012). Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3. Journal of Translational Medicine. 10(1). 249–249. 36 indexed citations
10.
Zhou, Juan, Mu-Yan Cai, Yi-Ji Liao, et al.. (2012). CHD1L Protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival. BMC Cancer. 12(1). 437–437. 40 indexed citations
11.
Zhao, Lei, Qiao-Qiao Li, Rui Zhang, et al.. (2012). The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin. Tumor Biology. 33(4). 1115–1123. 12 indexed citations
12.
Zhang, Jiaxing, Zhu‐Ting Tong, Jie-Wei Chen, et al.. (2012). Overexpression of the secretory small GTPase Rab27B in human breast cancer correlates closely with lymph node metastasis and predicts poor prognosis. Journal of Translational Medicine. 10(1). 242–242. 41 indexed citations
13.
Zhang, Jiaxing, Dong Qian, Feng-Wei Wang, et al.. (2012). MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy. Cancer Letters. 329(1). 91–98. 68 indexed citations
14.
Zhao, Lei, Li-Ru He, Rui Zhang, et al.. (2011). Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma. Medical Oncology. 29(4). 2669–2676. 18 indexed citations
15.
Wang, Feng-Wei, Xian-rui Wu, Yi-Ji Liao, et al.. (2011). Heat shock factor 1 upregulates transcription of Epstein–Barr Virus nuclear antigen 1 by binding to a heat shock element within the BamHI-Q promoter. Virology. 421(2). 184–191. 17 indexed citations
16.
Wu, Xian-rui, et al.. (2011). The nucleotide polymorphisms within the Epstein–Barr virus C and Q promoters from nasopharyngeal carcinoma affect transcriptional activity in vitro. European Archives of Oto-Rhino-Laryngology. 269(3). 931–938. 10 indexed citations
17.
Liao, Yi-Ji, et al.. (2010). Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells. European Journal of Pharmacology. 637(1-3). 16–21. 98 indexed citations
18.
Cai, Mu-Yan, Li-Ru He, Shi-Juan Mai, et al.. (2010). EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β1 and is a predictor of outcome in ovarian carcinoma patients. Carcinogenesis. 31(9). 1576–1583. 119 indexed citations
19.
Liao, Yi-Ji, Li-Ru He, Yangchao Chen, et al.. (2010). PYRIN domain of NALP2 inhibits cell proliferation and tumor growth of human glioblastoma. Plasmid. 64(1). 41–50. 11 indexed citations
20.
He, Li-Ru, Meng‐Zhong Liu, Binkui Li, et al.. (2009). Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma. BMC Cancer. 9(1). 461–461. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026